LACEY WILDEBOER: Open Payments
NPI 1477077089 · KENLY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$140 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $125 · 2025 $140
Food & beverage: $140
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $37 |
| ABBVIE INC. | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Abbott Laboratories | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: REPATHA, VRAYLAR, GEMTESA, REXULTI, JOT DX, VERQUVO.
Industry payments across NC — which companies pay providers there.
